ACB
MODV

Aristotle Capital Boston’s ModivCare MODV Stock Holding History

Aristotle Capital Boston’s Portfolio MODV Stock Details MODV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-429,276
Closed -$5.08M – 128
2024
Q4 		$5.08M Sell
429,276
-50,104
-10% -$793K 0.19% 109
2024
Q3 		$6.85M Buy
479,380
+3,177
+0.7% +$72.9K 0.23% 102
2024
Q2 		$12.5M Sell
476,203
-3,324
-0.7% -$84.1K 0.42% 84
2024
Q1 		$11.2M Sell
479,527
-4,243
-0.9% -$155K 0.34% 97
2023
Q4 		$21.3M Buy
483,770
+77,757
+19% +$3.07M 0.65% 68
2023
Q3 		$12.8M Buy
406,013
+66,263
+20% +$2.59M 0.41% 92
2023
Q2 		$15.4M Sell
339,750
-3,078
-0.9% -$183K 0.46% 82
2023
Q1 		$28.8M Buy
342,828
+12,141
+4% +$1.17M 0.89% 46
2022
Q4 		$29.7M Buy
330,687
+9,001
+3% +$803K 0.94% 43
2022
Q3 		$32.1M Sell
321,686
-15,598
-5% -$1.62M 1.08% 28
2022
Q2 		$28.5M Buy
337,284
+14,622
+5% +$1.48M 0.85% 48
2022
Q1 		$37.2M Sell
322,662
-12,385
-4% -$1.43M 0.94% 36
2021
Q4 		$49.7M Sell
335,047
-3,406
-1% -$527K 1.16% 24
2021
Q3 		$61.5M Buy
338,453
+153
+0% +$27.2K 1.44% 11
2021
Q2 		$57.5M Sell
338,300
-26,322
-7% -$3.94M 1.32% 16
2021
Q1 		$54M Sell
364,622
-23,909
-6% -$3.71M 1.2% 24
2020
Q4 		$53.9M Sell
388,531
-36,704
-9% -$4.55M 1.28% 23
2020
Q3 		$39.5M Sell
425,235
-62,134
-13% -$5.38M 1.14% 25
2020
Q2 		$38.5M Buy
487,369
+56,804
+13% +$3.84M 1.17% 29
2020
Q1 		$23.6M Buy
430,565
+5,549
+1% +$343K 1.01% 36
2019
Q4 		$25.2M Buy
425,016
+29,627
+7% +$1.81M 0.69% 64
2019
Q3 		$23.5M Buy
395,389
+50,635
+15% +$2.88M 0.69% 62
2019
Q2 		$19.8M Buy
344,754
+5,311
+2% +$344K 0.62% 71
2019
Q1 		$22.6M Buy
339,443
+132,565
+64% +$8.68M 0.75% 56
2018
Q4 		$12.4M Buy
206,878
+27,025
+15% +$1.79M 1.02% 41
2018
Q3 		$12.1M Buy
179,853
+291
+0.2% +$20.2K 0.89% 54
2018
Q2 		$14.1M Sell
179,562
-30,202
-14% -$2.27M 1.12% 32
2018
Q1 		$14.5M Buy
209,764
+5,490
+3% +$358K 0.68% 65
2017
Q4 		$12.1M Buy
204,274
+22,752
+13% +$1.29M 0.88% 45
2017
Q3 		$9.82M Sell
181,522
-603
-0.3% -$30.9K 0.88% 52
2017
Q2 		$9.22M Buy
182,125
+21,205
+13% +$975K 1.03% 32
2017
Q1 		$7.15M Buy
160,920
+23,197
+17% +$953K 0.95% 39
2016
Q4 		$5.24M Sell
137,723
-11,567
-8% -$469K 0.72% 63
2016
Q3 		$7.26M Sell
149,290
-31,668
-18% -$1.48M 1.29% 26
2016
Q2 		$8.12M Buy
180,958
+5,874
+3% +$286K 1.58% 15
2016
Q1 		$8.94M Buy
175,084
+14,339
+9% +$671K 1.79% 6
2015
Q4 		$7.54M Buy
160,745
+10,808
+7% +$519K 1.54% 14
2015
Q3 		$6.53M Buy
149,937
+967
+0.6% +$44.3K 1.6% 16
2015
Q2 		$6.6M Buy
148,970
+41,842
+39% +$1.99M 1.5% 18
2015
Q1 		$5.69M Buy
107,128
+38,666
+56% +$1.65M 1.77% 10
2014
Q4 		$2.5M Buy
+68,462
New +$2.68M 1.25% 29

Other funds holding MODV

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aristotle Capital Boston's MODV Position: Q1 2025 in Review

Aristotle Capital Boston sold out of ModivCare (MODV) in Q1 2025, closing a stake of 429,276 shares — an estimated $5.08M sold.

Aristotle Capital Boston first reported a position in MODV in Q4 2014 and held it in 41 quarters. The position peaked at $61.5M in Q3 2021. 91 funds tracked by Wall St. Rank hold MODV as of Q1 2025.

  • Aristotle Capital Boston reported no remaining ModivCare position as of Q1 2025 after selling out during the quarter.
  • Aristotle Capital Boston sold 429,276 ModivCare shares in Q1 2025, an estimated $5.08M.
  • Aristotle Capital Boston first reported a position in ModivCare in Q4 2014 and held it in 41 quarters.
  • Aristotle Capital Boston's ModivCare position peaked at $61.5M in Q3 2021.
  • 91 funds tracked by Wall St. Rank held ModivCare as of Q1 2025.

Based on Aristotle Capital Boston's 13F filing for Q1 2025, filed 15 May 2025.